ASSERTIO THERAPEUTICS, INC. Revenue
ASSERTIO THERAPEUTICS, INC. reported Revenue of $77.49 million for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-09.
Discontinued › Income Statement › Revenue
us-gaap:Revenues · last filed 2018-11-09
- ASSERTIO THERAPEUTICS, INC. revenues for the quarter ending 2018-09-30 was $77.49M, a 18.78% decline year-over-year.
- ASSERTIO THERAPEUTICS, INC. revenues for the quarter ending 2018-06-30 was $63.27M, a 37.01% decline year-over-year.
- ASSERTIO THERAPEUTICS, INC. revenues for the quarter ending 2018-03-31 was $128.40M, a 41.97% increase year-over-year.
- ASSERTIO THERAPEUTICS, INC. revenues for the quarter ending 2017-12-31 was $94.41M, a 23.81% decline year-over-year.
- ASSERTIO THERAPEUTICS, INC. revenues for fiscal 2017 was $380.72M, a 16.49% decline from fiscal 2016.
- ASSERTIO THERAPEUTICS, INC. revenues for fiscal 2016 was $455.90M, a 33.02% increase from fiscal 2015.
- ASSERTIO THERAPEUTICS, INC. revenues for fiscal 2015 was $342.74M, a 12.20% decline from fiscal 2014.
- ASSERTIO THERAPEUTICS, INC. revenues for fiscal 2014 was $390.36M, a 190.87% increase from fiscal 2013.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2018-09-30 | $77.49M 10-Q · filed 2018-11-09 | $140.77M derived: sum of 2 quarters · filed 2018-11-09 | $269.17M 10-Q · filed 2018-11-09 | $363.58M derived: sum of 4 quarters · filed 2018-11-09 |
| 2018-06-30 | $63.27M 10-Q · filed 2018-08-08 | $191.68M 10-Q · filed 2018-08-08 | $286.08M derived: sum of 3 quarters · filed 2018-08-08 | $381.50M derived: sum of 4 quarters · filed 2018-11-09 |
| 2018-03-31 | $128.40M 10-Q · filed 2018-05-10 | $222.81M derived: sum of 2 quarters · filed 2018-05-10 | $318.22M derived: sum of 3 quarters · filed 2018-11-09 | $418.68M derived: sum of 4 quarters · filed 2018-11-09 |
| 2017-12-31 | $94.41M 10-K · filed 2018-03-01 | $189.82M derived: sum of 2 quarters · filed 2018-11-09 | $290.28M derived: sum of 3 quarters · filed 2018-11-09 | $380.72M 10-K · filed 2018-03-01 |
| 2017-09-30 | $95.41M 10-Q · filed 2018-11-09 | $195.87M derived: sum of 2 quarters · filed 2018-11-09 | $286.32M 10-Q · filed 2018-11-09 | $410.23M derived: sum of 4 quarters · filed 2018-11-09 |
| 2017-06-30 | $100.46M 10-Q · filed 2018-08-08 | $190.90M 10-Q · filed 2018-08-08 | $314.81M derived: sum of 3 quarters · filed 2018-08-08 | $425.34M derived: sum of 4 quarters · filed 2018-08-08 |
| 2017-03-31 | $90.45M 10-Q · filed 2018-05-10 | $214.36M derived: sum of 2 quarters · filed 2018-05-10 | $324.88M derived: sum of 3 quarters · filed 2018-05-10 | $441.56M derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-12-31 | $123.91M 10-K · filed 2018-03-01 | $234.44M derived: sum of 2 quarters · filed 2018-03-01 | $351.12M derived: sum of 3 quarters · filed 2018-03-01 | $455.90M 10-K · filed 2018-03-01 |
| 2016-09-30 | $110.52M 10-K · filed 2018-03-01 | $227.21M derived: sum of 2 quarters · filed 2018-03-01 | $331.99M 10-Q · filed 2017-11-09 | $443.16M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-06-30 | $116.68M 10-K · filed 2018-03-01 | $221.46M 10-Q · filed 2017-08-07 | $332.63M derived: sum of 3 quarters · filed 2018-03-01 | $437.49M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-03-31 | $104.78M 10-K · filed 2018-03-01 | $215.95M derived: sum of 2 quarters · filed 2018-03-01 | $320.81M derived: sum of 3 quarters · filed 2018-03-01 | $415.31M derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-12-31 | $111.17M 10-K · filed 2017-02-24 | $216.03M derived: sum of 2 quarters · filed 2017-02-24 | $310.53M derived: sum of 3 quarters · filed 2017-02-24 | $342.74M 10-K · filed 2018-03-01 |
| 2015-09-30 | $104.86M 10-K · filed 2017-02-24 | $199.36M derived: sum of 2 quarters · filed 2017-02-24 | $231.56M 10-Q · filed 2016-11-07 | $426.16M derived: sum of 4 quarters · filed 2017-02-24 |
| 2015-06-30 | $94.50M 10-K · filed 2017-02-24 | $126.71M 10-Q · filed 2016-08-03 | $321.31M derived: sum of 3 quarters · filed 2017-02-24 | $372.79M derived: sum of 4 quarters · filed 2017-02-24 |
| 2015-03-31 | $32.20M 10-K · filed 2017-02-24 | $226.80M derived: sum of 2 quarters · filed 2017-02-24 | $278.29M derived: sum of 3 quarters · filed 2017-02-24 | $346.02M derived: sum of 4 quarters · filed 2017-02-24 |
| 2014-12-31 | $194.60M 10-K · filed 2016-02-26 | $246.09M derived: sum of 2 quarters · filed 2016-02-26 | $313.82M derived: sum of 3 quarters · filed 2016-02-26 | $390.36M 10-K · filed 2017-02-24 |
| 2014-09-30 | $51.48M 10-K · filed 2016-02-26 | $119.22M derived: sum of 2 quarters · filed 2016-02-26 | $195.76M 10-Q · filed 2015-11-09 | $236.37M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-06-30 | $67.73M 10-K · filed 2016-02-26 | $144.28M 10-Q · filed 2015-08-03 | $184.88M derived: sum of 3 quarters · filed 2016-02-26 | $222.34M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-03-31 | $76.54M 10-K · filed 2016-02-26 | $117.15M derived: sum of 2 quarters · filed 2016-02-26 | $154.61M derived: sum of 3 quarters · filed 2016-02-26 | $184.57M derived: sum of 4 quarters · filed 2016-02-26 |
| 2013-12-31 | $40.61M 10-K · filed 2015-02-26 | $78.07M derived: sum of 2 quarters · filed 2015-02-26 | $108.03M derived: sum of 3 quarters · filed 2015-02-26 | $134.21M 10-K · filed 2016-02-26 |
| 2013-09-30 | $37.46M 10-K · filed 2015-02-26 | $67.42M derived: sum of 2 quarters · filed 2015-02-26 | $93.60M 10-Q · filed 2014-11-06 | $120.19M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-06-30 | $29.96M 10-K · filed 2015-02-26 | $56.14M 10-Q · filed 2014-08-06 | $82.73M derived: sum of 3 quarters · filed 2015-02-26 | $116.01M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-03-31 | $26.17M 10-K · filed 2015-02-26 | $52.76M derived: sum of 2 quarters · filed 2015-02-26 | $86.05M derived: sum of 3 quarters · filed 2015-02-26 | $100.16M derived: sum of 4 quarters · filed 2015-02-26 |
| 2012-12-31 | $26.59M 10-K · filed 2014-03-17 | $59.87M derived: sum of 2 quarters · filed 2014-03-17 | $73.98M derived: sum of 3 quarters · filed 2014-03-17 | $90.82M 10-K · filed 2015-02-26 |
| 2012-09-30 | $33.28M 10-K · filed 2014-03-17 | $47.39M derived: sum of 2 quarters · filed 2014-03-17 | $64.23M 10-Q · filed 2013-11-07 | $76.36M derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-06-30 | $14.11M 10-K · filed 2014-03-17 | $30.95M 10-Q · filed 2013-08-08 | $43.08M derived: sum of 3 quarters · filed 2014-03-17 | $59.60M derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-03-31 | $16.84M 10-K · filed 2014-03-17 | $28.97M derived: sum of 2 quarters · filed 2014-03-17 | $45.49M derived: sum of 3 quarters · filed 2014-03-17 | $66.71M derived: sum of 4 quarters · filed 2014-03-17 |
| 2011-12-31 | $12.13M 10-K · filed 2013-02-22 | $28.65M derived: sum of 2 quarters · filed 2013-02-22 | $49.87M derived: sum of 3 quarters · filed 2013-02-22 | $132.97M 10-K · filed 2014-03-17 |
| 2011-09-30 | $16.52M 10-K · filed 2013-02-22 | $37.74M derived: sum of 2 quarters · filed 2013-02-22 | $120.84M 10-Q · filed 2012-11-05 | $141.70M derived: sum of 4 quarters · filed 2013-02-22 |
| 2011-06-30 | $21.22M 10-K · filed 2013-02-22 | $104.32M 10-Q/A · filed 2012-08-13 | $125.18M derived: sum of 3 quarters · filed 2013-02-22 | $145.31M derived: sum of 4 quarters · filed 2013-02-22 |
| 2011-03-31 | $83.10M 10-K · filed 2013-02-22 | $103.96M derived: sum of 2 quarters · filed 2013-02-22 | $124.09M derived: sum of 3 quarters · filed 2013-02-22 | $148.51M derived: sum of 4 quarters · filed 2013-02-22 |
| 2010-12-31 | $20.86M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22 | $40.99M derived: sum of 2 quarters · filed 2013-02-22 | $65.41M derived: sum of 3 quarters · filed 2013-02-22 | $80.76M 10-K · filed 2013-02-22 |
| 2010-09-30 | $20.13M 10-Q · filed 2011-11-07 | $44.55M derived: sum of 2 quarters · filed 2011-11-07 | $59.91M 10-Q · filed 2011-11-07 | |
| 2010-06-30 | $24.42M 10-Q · filed 2011-08-02 | $39.78M 10-Q · filed 2011-08-02 | ||
| 2009-12-31 | $57.73M 10-K · filed 2012-03-08 |